Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

This study has been terminated.
(As two cases of retinal vascular occlusion in patients who received anti-VEGF)
Information provided by (Responsible Party):
Steba Biotech S.A. Identifier:
First received: November 29, 2009
Last updated: April 27, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2014
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)